Get More Information on Contrast Media/Contrast Agent Market - Request Sample Report
The Contrast Media/Contrast Agent Market Size was valued at USD 6.50 Billion in 2023, and is expected to reach USD 12.28 Billion by 2032, and grow at a CAGR of 7.66%.
The growing need for diagnostic and image-guided operations, technical developments in the contrast media market, rising cancer and heart disease incidence and death rates, and the development of medical imaging technologies in emerging economies are the industry's key growth drivers. Older people are more likely to have chronic diseases with many comorbidities. The National Council on Ageing estimates that by 2030, there will be nearly 79.0 million people in the United States who are 60 or older, with nearly 82% of those people having at least one chronic condition and nearly 72% of Medicare beneficiaries having more than two.
Furthermore, heart failure is one of the major causes of mortality in the United States and is becoming increasingly common there, according to a report from the American Heart Association. About 662,000 Americans passed away in 2020 as a result of cardiovascular disorders. According to estimates, there will be 48% more people suffering from heart disease by 2030. The demand for diagnostic imaging treatments and, consequently, contrast media has significantly increased as a result of the growing incidence of chronic illnesses worldwide. To provide new goods to the market and get the contrast media authorized for new indications, contrast media makers have been doing substantial R&D as a consequence of the rising demand for imaging operations.
KEY DRIVERS:
The Rising Incidence of Chronic Diseases Such as Cancer, Cardiovascular Disorders, And Neurological Conditions Is Driving the Demand for Advanced Diagnostic Imaging Procedures.
Continuous Advancements in Imaging Technologies, such as the Development of More Precise and Efficient X-ray, CT, MRI, And Ultrasound Machines, Are Boosting the Use of Contrast Agents.
RESTRAINTS:
The High-Cost Associated with Contrast Agents and Diagnostic Imaging Procedures Can Be a Significant Barrier, Especially in Developing Regions with Limited Healthcare Budgets.
Although Generally Safe, The Use of Contrast Media can Sometimes Lead to Adverse Reactions, Such as Allergic Responses or Nephrotoxicity.
OPPORTUNITY:
The Ongoing Research and Development in the Field of Contrast Media Are Leading to New Applications and Formulations.
Emerging Economies in The Asia-Pacific, Latin America, And Middle East & Africa Regions Present Significant Growth Opportunities Due to Increasing Healthcare Awareness, Rising Disposable Incomes, and Improving Healthcare Infrastructure.
By Procedure
The X-ray/CT segment accounted for more than 60% in 2023. X-ray contrast agents allow for 3D imaging of structures at a very high resolution. Barium- and Iodinated Contrast Media for X-ray & CT When it comes to barium and iodine contrast agents, they are substances that block X-rays from passing through after being administered/injected within the body. Therefore, their appearance in images with a temporary accumulation of barium-based (gastrointestinal tract) or iodinated contrast agents is different organs, blood vessels, and other structures. The growth of the market is expected to be driven by widespread applications not only for X-ray lightning but also in CT (Computed Tomography) rather than for a single disease. The increasing use of imaging devices is expected to drive the demand for contrast media. As per OECD, in the year 2022, nearly 44 CT machines were available out of all 1000,000 inhabitants IN Denmark; these factors accelerate the growth prospectus.
By Type
An Iodinated Contrast Media holds 65% in 2023 & it is used to improve the visibility of vascular structures and organs during radiographic procedures. Iodinated contrast has increased visibility in the diagnosis of cancer. For that reason, a rising amount of cancer cases is anticipated to boost such a segment. For example, in 2023 an estimated almost 20 million new cancer cases occurred worldwide based on a recently released update from the Pan American Health Organization. Developing cancer rates to rise almost 60% in the next two decades. The predicted worldwide burden will also rise to around 30 million new cancer cases by the year 2040, with large increases anticipated in low and middle-income nations. Hence, the increasing incidence of cancer is likely to propel the segment.
In 2023, North America accounted for the largest market share at around 40%. Intended targeted patient subsets and strategic attempts for expansion by key manufacturers are anticipated to fuel market growth in this space. Major Industry Players– Bayer GE Healthcare, Guerbet Lantheus, Bracco Diagnostics, present in North America. Rising prevalence and diagnosis rates of respiratory diseases coupled with a growing number of diagnostic imaging procedures performed in hospitals are key factors contributing to its large share Nevertheless, healthcare reforms and appropriate use criteria may reduce the number of procedures.
Asia Pacific is likely to register the highest CAGR during the forecast period That is primarily due to the availability of as many renowned global & local producers in this area. GE Pharmaceuticals (Shanghai) is a subsidiary of GE in China and used to be the largest production base for contrast media of GE Healthcare worldwide. Demand is expected to be fueled by the economic growth of countries such as China and India, aiding in market penetration. Due to the larger population size and less per capita income in Asia Pacific, there is a high need for affordable treatment options.
APAC countries like India, which is in the developing stage globally attract international businesses to invest. As a result, many players in the market are entering into strategic and cooperative partnerships with regional participants. The contrast media industry is moving up with the rise in the elderly population of the region, enhanced penetration of chronic diseases among older people, and increasing prevalence of chronic and other deadly diseases over some time. Furthermore, the market is expected to be propelled throughout the forecast period due to improvements in healthcare infrastructure and an increase in diagnostic imaging examinations.
Need any customization research on Contrast Media/ Contrast Agent Market - Enquiry Now
The key market players are Bayer AG, Bracco Diagnostic Inc., GE Healthcare, Guerbet Group, Lantheus Medical Imaging Inc., Spago Nanomedical AB, FUJIFILM Corporation, Beijing Beilu Pharmaceutical Co. Ltd., Taejoon Pharm Co. Ltd. & other players.
Pixxoscan (gadobutrol), a non-ionic macrocyclic GBCA for MRI was launched by GE HealthCare in April 2023. Pixxoscan has undergone regulatory evaluation via the decentralized procedure (DCP) and will be available in multiple European markets by 2023 with a marketing authorization secured in Austria, and further EU countries pending. It was anticipated to drive the contrast media market over the forecasted period for the industry in this region.
|
Report Attributes |
Details |
|
Market Size in 2023 |
US$ 6.50 Billion |
|
Market Size by 2032 |
US$ 12.28 Billion |
|
CAGR |
CAGR of 7.66% From 2024 to 2032 |
|
Base Year |
2023 |
|
Forecast Period |
2024-2032 |
|
Historical Data |
2020-2022 |
|
Report Scope & Coverage |
Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
|
Key Segments |
•By Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media & Barium-based Contrast Media) |
|
Regional Analysis/Coverage |
North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
|
Company Profiles |
American addiction Centres, Magellan Health Inc., Springstone, Universal Healthcare Services Inc., Behavioral Health Group, Peoples Care Holding Inc., Acadia HealthCare & Other players |
|
Key Drivers |
•The Rising Incidence of Chronic Diseases Such as Cancer, Cardiovascular Disorders, And Neurological Conditions Is Driving the Demand for Advanced Diagnostic Imaging Procedures. |
|
RESTRAINTS |
•The High-Cost Associated with Contrast Agents and Diagnostic Imaging Procedures Can Be a Significant Barrier, Especially in Developing Regions with Limited Healthcare Budgets. |
Ans: The Contrast Media/Contrast Agent Market size was valued at US$ 6.50 billion in 2023.
Ans: The Contrast Media/Contrast Agent Market is to grow at a CAGR of 7.66% over the forecast period 2024-2032.
The market is divided into six segments and the segments are By Type, By Route of Administration, By Modality, By Application, By Indication, and By End User
The challenges faced by contrast media/contrast agent Market is Scarcity of qualified professionals, and Rise in price and side effect.
key drivers of the contrast media/contrast agent Market is the factors that encourage product development, and Gaining popularity
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Adoption Rates, 2023
5.2 User Demographics, By User Type and Roles, 2023
5.3 Feature Analysis, by Feature Type
5.4 Cost Analysis, by Software
5.5 Integration Capabilities
5.6 Regulatory Compliance, by Region
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Contrast Media/ Contrast Agent Market Segmentation, by Type
7.1 Chapter Overview
7.2 Iodinated Contrast Media
7.2.1 Iodinated Contrast Media Market Trends Analysis (2020-2032)
7.2.2 Iodinated Contrast Media Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Gadolinium-based Contrast Media
7.3.1 Gadolinium-based Contrast Media Market Trends Analysis (2020-2032)
7.3.2 Gadolinium-based Contrast Media Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Microbubble Contrast Media
7.4.1 Microbubble Contrast Media Market Trends Analysis (2020-2032)
7.4.2 Microbubble Contrast Media Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Barium-based Contrast Media
7.5.1 Barium-based Contrast Media Market Trends Analysis (2020-2032)
7.5.2 Barium-based Contrast Media Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Contrast Media/ Contrast Agent Market Segmentation, by Procedure
8.1 Chapter Overview
8.2 X-ray/Computed Tomography (CT)
8.2.1 X-ray/Computed Tomography (CT) Market Trends Analysis (2020-2032)
8.2.2 X-ray/Computed Tomography (CT) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Magnetic Resonance Imaging (MRI)
8.3.1 Magnetic Resonance Imaging (MRI) Market Trends Analysis (2020-2032)
8.3.2 Magnetic Resonance Imaging (MRI) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Ultrasound
8.4.1 Ultrasound Market Trends Analysis (2020-2032)
8.4.2 Ultrasound Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Contrast Media/ Contrast Agent Market Segmentation, by Indication
9.1 Chapter Overview
9.2 Cardiovascular Disease
9.2.1 Cardiovascular Disease Market Trends Analysis (2020-2032)
9.2.2 Cardiovascular Disease Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Oncology
9.3.1 Oncology Market Trends Analysis (2020-2032)
9.3.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Gastrointestinal Disorders
9.4.1 Gastrointestinal Disorders Market Trends Analysis (2020-2032)
9.4.2 Gastrointestinal Disorders Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Neurological Disorders
9.5.1 Neurological Disorders Market Trends Analysis (2020-2032)
9.5.2 Neurological Disorders Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Others
9.6.1 Others Market Trends Analysis (2020-2032)
9.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.2.5 North America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.2.6.3 USA Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.2.7.3 Canada Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.2.8.3 Mexico Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.6.3 Poland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.7.3 Romania Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.5 Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.6.3 Germany Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.7.3 France Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.8.3 UK Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.9.3 Italy Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.10.3 Spain Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.13.3 Austria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.5 Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.6.3 China Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.7.3 India Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.8.3 Japan Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.9.3 South Korea Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.10.3 Vietnam Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.11.3 Singapore Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.12.3 Australia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.5 Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.6.3 UAE Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.2.5 Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.6.5 Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.6.6.3 Brazil Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.6.7.3 Argentina Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.6.8.3 Colombia Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Procedure (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Contrast Media/ Contrast Agent Market Estimates and Forecasts, by Indication (2020-2032) (USD Billion)
11. Company Profiles
11.1 Bayer AG
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Bracco Diagnostic Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Guerbet Group
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Lantheus Medical Imaging Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Spago Nanomedical AB
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 FUJIFILM Corporation
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Beijing Beilu Pharmaceutical Co. Ltd.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Taejoon Pharm Co. Ltd.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Barium-based Contrast Media
By Procedure
X-ray/Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
By Indication
Cardiovascular Disease
Oncology
Gastrointestinal Disorders
Neurological Disorders
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five
The Fibromyalgia Treatment Market Size was valued at USD 3.32 billion in 2023, and is expected to reach USD 4.7 billion by 2032, and grow at a CAGR of 3.9% over the forecast period 2024-2032.
The Biotechnology Reagents & Kits Market size was valued at USD 563.19 billion in 2023 and is expected to reach USD 1441.03 billion by 2032 at a CAGR of 11.04% during the forecast period of 2024-2032.
The Next-Generation Sequencing Market size was estimated at USD 8.3 billion in 2023 and is expected to reach USD 50.0 billion by 2032 with a growing CAGR of 22.0% during the forecast period of 2024-2032.
The Medical Batteries Market size is projected to reach USD 4.11 billion by 2032 and was valued at USD 2.20 billion by 2023. The expected CAGR for 2024-2032 is 6.52%.
The Laboratory Freezers Market was valued at USD 4.97 Billion in 2023 and is projected to reach USD 7.88 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.31% from 2024 to 2032.
The Cystic Fibrosis Market size was valued at USD 6.02 billion in 2023, and is expected to reach USD 10.85 billion by 2032, and grow at a CAGR of 6.83% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
